Back
EyePoint Pharmaceuticals Vs. Lemonade Industry Stock Comparison
Buy
61
EYPT
EyePoint Pharmaceuticals
Last Price:
10.74
Seasonality Move:
27.28%
Buy
91
LMND
Lemonade
Last Price:
32.01
Seasonality Move:
29.67%
Buy
61
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $11.11. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
91
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $32.27. The Score for LMND is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $11.11
The current trend is moderately bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 52.97 | Buy |
| Chaikin Money Flow: | -601272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.47 - 11.93) | Buy |
| Bollinger Bands (100): | (8.04 - 10.4) | Buy |
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.5 | Buy |
| Relative Strength Index (14 RSI): | 74.87 | Buy |
| Chaikin Money Flow: | -2225126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.38 - 26.6) | Buy |
| Bollinger Bands (100): | (15.39 - 22.43) | Buy |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.72 | Sell |
| 20-day SMA: | 11.17 | Sell |
| 50-day SMA: | 9.56 | Buy |
| 200-day SMA: | 14.29 | Sell |
| 8-day EMA: | 11.55 | Sell |
| 20-day EMA: | 11.03 | Buy |
| 50-day EMA: | 10.16 | Buy |
| 200-day EMA: | 11.64 | Sell |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.04 | Buy |
| 20-day SMA: | 22.66 | Buy |
| 50-day SMA: | 19.53 | Buy |
| 200-day SMA: | 17.84 | Buy |
| 8-day EMA: | 28.45 | Buy |
| 20-day EMA: | 24.22 | Buy |
| 50-day EMA: | 20.89 | Buy |
| 200-day EMA: | 18.31 | Buy |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.43 per share.
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.
EyePoint Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lemonade Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||